ArticleCureus2026
Primary Breast Angiosarcoma: A Report of a Rare Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast angiosarcomas are a rare type of cancer, comprising only a small percentage of all malignant breast tumors. They can be divided into two main types: primary angiosarcoma, which develops in the absence of any pre-existing condition, and secondary angiosarcoma, which most often arises in previously irradiated breast tissue or following any other disorders affecting the breast. The primary one is an aggressive tumor, whereas the secondary may behave differently due to its relation with previous treatments. These differences need to be distinguished for the correct diagnosis and effective management. A 71-year-old woman with a personal history of hypothyroidism and benign breast lumpectomies presented to our clinic with a right breast mass. Initial imaging suggested a fibroadenoma, but after the excision of the tumor, it was identified as grade III angiosarcoma. The patient declined mastectomy, choosing local excision and surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.